Skip to main content

Want a detailed portfolio tracker?

Nyxoah (NYXH) Market Cap (2021 - 2026)

Nyxoah (NYXH) market cap from Apr 28, 2021 to Jul 20, 2026. The current Nyxoah (NYXH) market cap is $67M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Market Cap

Nyxoah (NYXH) Market Cap CAGR table

PeriodCAGR
1 Year TTM-42.77%
3 Years TTM-2.27%
5 Years TTM+4.45%
All Time TTM-25.41%

Annual Market Cap change of Nyxoah (NYXH)

YearMarket CapChange
2026$67M-63.48%
2025$185M-37.71%
2024$296M+122.76%
2023$133M+3.17%
2022$129M-78.19%
2021$591MN/A

Comparison Nyxoah (NYXH) market cap with competitors

Nyxoah (NYXH) market cap is $67.41M.

TickerNameMarket CapUpside
ISRGIntuitive Surgical Inc$137.85B+204409.88%
BDXBecton Dickinson & Company$43.47B+64387.78%
ALCAlcon Inc$33.58B+49723.22%
RMDResmed Inc$28.80B+42627.41%
WSTWest Pharmaceutical Services Inc$25.45B+37661.15%
HOLXHologic Inc$17.06B+25205.08%
COOCooper Companies Inc$13.76B+20313.67%
SOLVSolventum Corp$13.60B+20075.91%
ALGNAlign Technology Inc$12.98B+19158.51%
BAXBaxter International Inc$11.41B+16823.32%
RGENRepligen Corp$8.35B+12288.42%
ATRAptargroup Inc$8.27B+12166.37%
AVTRAvantor Inc$7.64B+11231.77%
TFXTeleflex Incorporated$5.83B+8550.42%
BLCOBausch + Lomb Corp$5.81B+8518.38%
STVNStevanato Group Spa$5.16B+7555.30%
MMSIMerit Medical Systems Inc$4.36B+6364.16%
NVSTEnvista Holdings Corp$4.35B+6355.05%
ICUIICU Medical Inc$3.95B+5756.93%
WRBYWarby Parker Inc - Class A$3.45B+5011.09%
XRAYDENTSPLY Sirona Inc$2.68B+3881.90%
LMATLemaitre Vascular Inc$2.28B+3282.48%
PLSEPulse Biosciences Inc$1.80B+2564.00%
ATRCAtricure Inc$1.75B+2494.59%
KMTSKestra Medical Technologies Ltd$1.44B+2032.05%
BLFSBiolife Solutions Inc$1.42B+2011.48%
STAAStaar Surgical Company$1.42B+2004.77%
AZTAAzenta Inc$1.23B+1726.41%
AVRAnteris Technologies Global Corp$844.95M+1153.53%
ANGOAngiodynamic Inc$603.41M+795.19%
NNNNAnbio Biotechnology - Class A$398.29M+490.88%
OSUROrasure Technologies Inc$294.94M+337.56%
SMTISanara MedTech Inc$224.78M+233.47%
UTMDUtah Medical Products Inc$224.22M+232.64%
EMBCEmbecta Corp$191.04M+183.41%
KRMDKORU Medical Systems Inc$190.53M+182.66%
PDEXPro-Dex Inc (co)$180.74M+168.13%
STXSStereotaxis Inc$160.20M+137.67%
MBOTMicrobot Medical Inc$124.91M+85.32%
ZTEKZentek Ltd$53.36M-20.84%
POCIPrecision Optics Corp Inc$51.59M-23.46%
STSSSharps Technology Inc$48.88M-27.48%
DXRDaxor Corp$44.78M-33.57%
EKSOEkso Bionics Holdings Inc$42.04M-37.63%
NEPHNephros Inc$39.47M-41.44%
MLSSMilestone Scientific Inc$34.16M-49.32%
HBIOHarvard Bioscience Inc$27.20M-59.65%
RVPRetractable Technologies Inc$21.55M-68.02%
ZJYLJin Medical International Ltd$15.19M-77.47%
BNGOBionano Genomics Inc$13.42M-80.09%
RGNTRegentis Biomaterials Ltd$12.59M-81.33%
FEMYFemasys Inc$10.78M-84.01%
CUPRCuprina Holdings (Cayman) Ltd - Class A$10.77M-84.02%
LUCYInnovative Eyewear Inc$6.74M-90.00%
NXGLNexgel Inc$3.90M-94.22%
MHUAMeihua International Medical Technologies Co Ltd - Class A$2.43M-96.40%
GCTKGlucoTrack Inc$725818.34-98.92%
BIPHBrookfield Infrastructure Finance ULC$351137.45-99.48%